Patent details
91927 Product Name: "Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)"
Basic Information
- Publication number:
- 91927
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP969429018
- Legal Status:
- Lapsed
- Application number:
- 91927
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/11/698/001-002 - YERVOY - Ipilimumab
- Marketing Authorization Type:
- Marketing Authorization Date:
- 13/07/2011
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 09/01/2012
- First Marketing Authorization date:
- 13/07/2011
- Grant date:
- 09/03/2012
- Activation date:
- 04/12/2016
- Publication date:
- 09/03/2012
- Lapsed date:
- 04/12/2016
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 04/12/2021
- SPC Extension Expiration:
- 04/12/2021
- Rejection date:
- Withdrawal date:
Owner
- From:
- 09/01/2012
- Name:
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Address:
- 1111 FRANKLIN STREET, OAKLAND CA 94607, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 09/01/2012
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KRUMMEL Matthew, F.
- Address:
- United States (US)
2
- Name:
- ALLISON James, Patrick
- Address:
- United States (US)
3
- Name:
- LEACH Dana, R.
- Address:
- United States (US)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2017/01
- Publication date:
- 16/03/2017
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|